TrialArchives of dermatological research2023

Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.

Hee J Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.